Loading...
XSHG
600998
Market cap3.64bUSD
Dec 05, Last price  
5.11CNY
1D
0.59%
1Q
3.65%
Jan 2017
-48.59%
IPO
-39.02%
Name

Jointown Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHG:600998 chart
P/E
10.28
P/S
0.17
EPS
0.50
Div Yield, %
4.89%
Shrs. gr., 5y
3.18%
Rev. gr., 5y
8.82%
Revenues
151.81b
+1.11%
13,048,102,60516,287,598,13618,957,708,89521,251,772,76424,838,678,87529,507,662,75733,438,049,66541,068,404,47849,589,246,31261,556,839,88573,942,894,40387,136,358,55399,497,077,396110,859,514,087122,407,434,023140,424,191,627150,139,846,735151,809,799,000
Net income
2.51b
+15.33%
159,783,448202,635,778297,891,827353,427,258374,134,158412,720,761477,927,812560,706,759694,534,909876,741,8151,445,510,1021,340,578,8241,726,549,4793,075,054,8232,448,334,1822,084,962,5392,174,042,8382,507,392,000
CFO
3.08b
-35.54%
65,952,703494,748,8270000138,468,5820435,955,993431,263,75201,222,023,1642,767,873,0483,443,884,1083,459,045,0573,986,228,1564,782,206,8203,082,502,072
Dividend
Jun 07, 20240.25 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jointown Pharmaceutical Group Co., Ltd provides marketing, distribution, and logistics services for digital pharmaceutical businesses. It wholesales Chinese herbal medicines, Chinese patent medicines, chemical medicinal materials, chemical medicine preparations, antibiotic preparations, biochemical drugs, biological products, chemical raw materials, and medical toxic drugs. The company was founded in 1999 and is based in Wuhan, China.
IPO date
Nov 02, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT